Half of Transcatheter Heart Valves Degenerate Within 10 Years
New reports from EuroPCR 2016 reveal that half of transcatheter heart valves undergo degeneration within 10 years. Findings from the first study... Read more
Myocardial Fibrosis Identified as New Therapeutic Target
Myocardial fibrosis could be a future therapeutic target after researchers found it correlated with adverse cardiovascular outcomes in patients... Read more
Virtual Heart Predicts Risk of Sudden Cardiac Death
There are many people who die suddenly, even though they had no risk factors for heart disease. It is believed that in the majority of... Read more
Artificial Intelligence: a next way forward for healthcare
Chelsea Beecher serves as the Director of Development for the American Heart & Stroke Association in New York City. She led the launch of STEM Goes Red in New York City and received the Innovator of the Year Award in 2018 for this initiative. STEM Goes Red aims to empower young women to pursue science, technology, engineering, and math (STEM)... Read more
Robots were first used in cardiovascular medicine in the late 1990s as a part of the digital revolution . Since then, robotics have been applied to endovascular surgery, minimally invasive cardiac surgery, and interventional cardiology, to name a few fields. Robots give medical professionals the ability to diagnose, treat, and intervene more... Read more
Executive Director & HealthManagement
Most people don't think much about stethoscopes but the fact is that this tool, so commonly associated with doctors, is at a crossroads. Having been in use for nearly two centuries, the stethoscope is in the midst of a debate with respect to its utility in healthcare. Over the years, medical technology has advanced to a great extent. The sounds... Read more
HealthManagement.org Welcomes New IT Editor-in-Chief
HealthManagement.org is excited to introduce our new Editor-in-Chief for... Read more
The CNAP® Monitor represents the next generation of noninvasive patient monitoring by merging the advantages of noninvasive, risk‐free methods with the benefits of continuity in the same accuracy as invasive standards. The advanced parameter set enables...
The Task Force® Monitor is the all‐in‐one workstation for continuous noninvasive hemodynamic and autonomic assessment. It is the state‐of‐the‐art diagnostic tool to study syncope and autoregulation of blood pressure and has further established as an...